| All | No prior CVD group | Prior CVD group |
---|---|---|---|
(n = 9340) | (n = 1748) | (n = 7592) | |
Age (years) | 64.3 ± 7.2 | 65.8 ± 5.2 | 63.9 ± 7.6 |
Gender | |||
 Female | 3337 (35.7 %) | 793 (45.4 %) | 2544 (33.5 %) |
 Male | 6003 (64.3 %) | 955 (54.6 %) | 5048 (66.5 %) |
Age group | |||
 50–59 years | 2321 (24.9 %) | 26 (1.5 %) | 2295 (30.2 %) |
 60–69 years | 4839 (51.8 %) | 1337 (76.5 %) | 3502 (46.1 %) |
 70–79 years | 1977 (21.2 %) | 359 (20.5 %) | 1618 (21.3 %) |
 80–89 years | 199 (2.1 %) | 26 (1.5 %) | 173 (2.3 %) |
 90–99 years | 4 (0.0 %) | 0 (0.0 %) | 4 (0.1 %) |
BMI (kg/m2) | |||
 <25.0 | 865 (9.3 %) | 172 (9.8 %) | 693 (9.1 %) |
 25 to <30 | 2671 (28.6 %) | 520 (29.7 %) | 2151 (28.3 %) |
 30 to <35 | 2987 (32.0 %) | 535 (30.6 %) | 2452 (32.3 %) |
 35 to <40 | 1715 (18.4 %) | 310 (17.7 %) | 1405 (18.5 %) |
 ≥40.0 | 1092 (11.7 %) | 210 (12.0 %) | 882 (11.6 %) |
WC ATIII target | |||
 Yes | 1933 (20.7 %) | 338 (19.3 %) | 1595 (21.0 %) |
 No | 7330 (78.5 %) | 1398 (80.0 %) | 5932 (78.1 %) |
 Missing values | 77 (0.8 %) | 12 (0.7 %) | 65 (0.9 %) |
WC-IISHMS target | |||
 Yes | 585 (6.3 %) | 100 (5.7 %) | 485 (6.4 %) |
 No | 8678 (92.9 %) | 1636 (93.6 %) | 7042 (92.8 %) |
 Missing values | 77 (0.8) | 12 (0.7) | 65 (0.9 %) |
HbA1c (%) | 8.7 (1.6) | 8.8 (1.5) | 8.7 (1.6) |
HbA1c (mmol/mol) | 71.6 (17.5) | 72.7 (16.4) | 71.6 (17.5) |
Blood lipids | |||
 LDL-C (mmol/L) | 2.3 (0.9) | 2.5 (0.9) | 2.3 (0.9) |
 HDL-C (mmol/L) | 1.2 (0.3) | 1.2 (0.3) | 1.2 (0.3) |
 Triglycerides (mmol/L) | 2.1 (1.6) | 2.0 (1.5) | 2.1 (1.6) |
No OAD use at baseline | 4409 (47.2Â %) | 744 (42.6Â %) | 3665 (48.3Â %) |
Pre-treatment | |||
 None/diet | 504 (5.4) | 99 (5.7) | 405 (5.3) |
 Insulines only | 665 (7.1) | 69 (3.9) | 596 (7.9) |
 OADs only | 4931 (52.8) | 1004 (57.4) | 3927 (51.7) |
 Ins + OADs | 3240 (34.7) | 576 (33.0) | 2644 (35.1) |
Use of antihypertensive medication | |||
 Yes | 8550 (91.5 %) | 1473 (84.3 %) | 7077 (93.2 %) |
 No | 790 (8.5 %) | 275 (15.7 %) | 515 (6.8 %) |